Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alefacept showed some effectiveness for alopecia areata but needs more research.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

New acne treatments show promise as alternatives to traditional therapies.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

BTA safely and effectively treats hair loss, and works better with FNS.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Effective symptom management in IBD improves quality of life and prevents complications.

Hair loss is common in IBD patients, and some medications may lower the risk.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.